Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Clinical trial NCT01795924 · TERMINATED
Trial details
- NCT number
- NCT01795924
- Sponsor
- Biosuccess Biotech Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2014-09-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.